Cargando…
FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
BACKGROUND: 2-deoxy-2-[18F]fluoro-d-glucose’s (FDG) biodistribution limits the evaluation of cardiac sarcoidosis (CS) and neurosarcoidosis (NS). While protocols for cardiac suppression exist, they can be inconvenient for patients and lead to incomplete cardiac suppression in many cases. Furthermore,...
Autores principales: | Martineau, Patrick, Pelletier-Galarneau, Matthieu, Juneau, Daniel, Leung, Eugene, Nery, Pablo, deKemp, Rob, Beanlands, Rob, Birnie, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728930/ https://www.ncbi.nlm.nih.gov/pubmed/33301054 http://dx.doi.org/10.1186/s13550-020-00742-x |
Ejemplares similares
-
Atypical Muscular Sarcoidosis Involvement Revealed by
(18)
F-FDG PET/CT
por: Lucinian, Yousif A., et al.
Publicado: (2022) -
Investigating the treatment phenotypes of cardiac sarcoidosis: A prospective cohort study()
por: Wiefels, Christiane, et al.
Publicado: (2022) -
Negative Association of Smoking History With Clinically Manifest Cardiac Sarcoidosis: A Case-Control Study
por: Xu, Chenchen, et al.
Publicado: (2022) -
Exploring Occupational, Recreational, and Environmental Associations in Patients With Clinically Manifest Cardiac Sarcoidosis
por: Spence, Stewart D., et al.
Publicado: (2020) -
(82)Rb PET imaging of myocardial blood flow—have we achieved the 4 “R”s to support routine use?
por: deKemp, Robert A., et al.
Publicado: (2016)